Open AccessGemini Curcumin Suppresses Gastric Cancer AGS Cell Proliferation Through Modulation of lncRNA
Author(s) -
Nasim JABBARI,
Salar Hafez Ghoran,
Haniyeh SEMSARI,
Bashdar Mahmud Hussen,
Esmaeil Babaei
Publication year - 2021
Publication title -
turkish journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.241
H-Index - 14
eISSN - 2148-6247
pISSN - 1304-530X
DOI - 10.4274/tjps.galenos.2021.03502
Subject(s) - curcumin , blot , carcinogenesis , chemistry , real time polymerase chain reaction , cancer , cancer research , cell growth , cell , microbiology and biotechnology , viability assay , biology , gene , biochemistry , genetics
Gemini surfactant nanocurcumin (Gemini-Cur) is a novel formulation of Curcumin (Cur) with dramatic suppressive effects on cancer cells. Here, we investigated the cancer effects of Gemini-Cur in a human gastric adenocarcinoma cell-line (AGS) through the evaluation of the expression of long non-coding RNAs colon cancer-associated transcript-2 ( CCAT2 ) and its downstream c-Myc as known oncogenic modulators of tumorigenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom